These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12089761)

  • 1. Tooth loss and hormone use in postmenopausal women.
    Grodstein F; Colditz GA; Stampfer MJ
    Compend Contin Educ Dent Suppl; 1998; (22):S9-16. PubMed ID: 12089761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy--something to smile about.
    Paganini-Hill A
    Compend Contin Educ Dent Suppl; 1998; (22):S4-8. PubMed ID: 12089760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal estrogen replacement and tooth retention.
    Krall EA; Dawson-Hughes B; Hannan MT; Kiel DP
    Compend Contin Educ Dent Suppl; 1998; (22):S17-22. PubMed ID: 12089757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-menopausal hormone use and tooth loss: a prospective study.
    Grodstein F; Colditz GA; Stampfer MJ
    J Am Dent Assoc; 1996 Mar; 127(3):370-7, quiz 392. PubMed ID: 8819784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone use and cholecystectomy in a large prospective study.
    Grodstein F; Colditz GA; Stampfer MJ
    Obstet Gynecol; 1994 Jan; 83(1):5-11. PubMed ID: 8272307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of estrogen replacement therapy on oral health. The Leisure World cohort.
    Paganini-Hill A
    Arch Intern Med; 1995 Nov; 155(21):2325-9. PubMed ID: 7487257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone therapy and migraine headache.
    Misakian AL; Langer RD; Bensenor IM; Cook NR; Manson JE; Buring JE; Rexrode KM
    J Womens Health (Larchmt); 2003 Dec; 12(10):1027-36. PubMed ID: 14709191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.
    Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of smoking on estradiol metabolism.
    Tansavatdi K; McClain B; Herrington DM
    Minerva Ginecol; 2004 Feb; 56(1):105-14. PubMed ID: 14973414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
    Chan MF; Dowsett M; Folkerd E; Wareham N; Luben R; Welch A; Bingham S; Khaw KT
    Menopause; 2008; 15(2):332-9. PubMed ID: 17667152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
    Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
    J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis risk factors in female dental patients. A preliminary report.
    Becker AR; Handick KE; Roberts WE; Garetto LP
    J Indiana Dent Assoc; 1997; 76(2):15-9; quiz 20. PubMed ID: 9517361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y; Page DL; Lane DS; Rohan TE
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
    Sirola J; Kröger H; Honkanen R; Sandini L; Tuppurainen M; Jurvelin JS; Saarikoski S
    Osteoporos Int; 2003 Jan; 14(1):27-33. PubMed ID: 12577182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA; Geusens PP; Nagtzaam IF; van der Voort DJ; Schreurs CM; Rinkens PE; Dinant GJ
    Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
    Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.